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Abstract
Intrauterine growth restriction (IUGR) is caused by dysregulation of placental metabolism. Pater-
nally inherited IUGR mutations in the fetus influence maternal physiology via the placenta. How-
ever, it is not known whether the maternal placenta also affects the extent of IUGR in such fetuses.
In cattle and other ruminants, maternal–fetal communication occurs primarily at the placentomes.
We previously identified a 3′ deletion in the noncodingMER1 repeat containing imprinted transcript
1 (MIMT1) gene that, when inherited from the sire, causes IUGR and late abortion in Ayshire cattle
with variable levels of severity. Here, we compared the transcriptome and genomic imprinting
in fetal and maternal placentome components of wild-type and MIMT1Del/WT fetuses before IUGR
became apparent, to identify key early events. Transcriptome analysis revealed fewer differentially
expressed genes in maternal than fetal MIMT1Del/WT placentome. AST1, within the PEG3 domain,
was the only gene consistently reduced in IUGR in both fetal and maternal samples. Several genes
showed an imprinting pattern associated with IUGR, of which only secernin 3 (SCRN3) and pa-
ternally expressed 3 (PEG3) were differentially imprinted in both placentome components. Loss
of strictly monoallelic, allele-specific expression (∼80:20) of PEG3 in the maternal MIMT1Del/WT
placenta could be associated with incomplete penetrance of MIMT1Del. Our data show that dys-
regulation of the PEG3 domain is involved in IUGR, but also reveal that maternal placental tissues
may affect the penetrance of the paternally inherited IUGR mutation.
Summary Sentence
Aberrant expression of imprinted genes specifically in maternal placental tissues affects the pene-
trance of a paternally inherited IUGR mutation in cattle.
C© The Authors 2017. Published by Oxford University Press on behalf of Society for the Study of Reproduction. All rights reserved.
For permissions, please e-mail: journals.permissions@oup.com
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Introduction
Growth of the developing fetus is determined by placental func-
tion. Placental weight correlates with birth weight and is a good
indicator of the placenta’s capacity to support fetal growth [1]. In-
trauterine growth restriction (IUGR) is mainly caused by external
and maternal factors leading to placental dysfunction [2], but can
also result from abnormal expression of paternally inherited genes.
Severe IUGR results in late abortion, stillbirth, and neonatal com-
plications in humans [3] and domestic animals [4]. It is well known
that maternal genotype influences fetal growth [5]. However, it is
difficult to discern the effect of the fetal genome on maternal physi-
ology, because of confounding effects of both maternal metabolism
and physiology on fetal growth and the fetal inheritance of mater-
nal genes [6]. Polymorphisms in fetal-imprinted genes are associated
with aberrant placental gene expression and maternal placental hor-
mone concentrations in women carrying fetuses with growth dis-
turbances such as Beckwith–Wiedemann syndrome (BWS) [7]. BWS
varies considerably in severity [8] and causative mutations exhibit
variable penetrance. It has also been shown that normal female mice
gestating pups carrying knockout mutations of imprinted insulin-like
growth factor 2 P0 transcript (P0-Igf2) and cyclin-dependent kinase
inhibitor 1C (Cdkn1c), p57Kip2 genes causing restricted fetal growth
can develop hypertension during pregnancy, indicating that the fetal
genome affects maternal physiology [9, 10]. These phenomena reflect
the complex, reciprocal nature of fetal–maternal communication in
animals and human placenta [11].
Placental morphology varies considerably between mammals
[12], but several factors involved in placental response to mater-
nal stress [2, 13] and fetal growth restriction are common between
species, including humans [14–16]. Transcriptome analysis of iso-
lated maternal or fetal placental tissues is a powerful means of
Figure 1. (A) Schematic presentation of the PEG3 domain in cattle. Paternally expressed genes are marked in blue and maternally expressed genes in red. (B)
Experimental design used to study the effect of IUGR paternal origin genotype on fetal and maternal placentome components in cattle. “Validation” refers to
qPCR and pyrosequencing.
identifying cell–cell communication at the feto–maternal interface
[17]. Samples of human and rodent placenta are however mixtures
of maternal and fetal cells that cannot easily be disassociated, so
comparative analysis of maternal and fetal sides is currently limited
to cells cultured in vitro, which risks altering gene expression due
to culture conditions and disrupted communication with adjacent
cells [18, 19]. Ruminants such as cattle have the advantage that the
principal site of fetal–maternal communication [20–22], the placen-
tome, can readily be separated during the first months of gestation,
enabling analysis of each side. Placentomes are small areas of inti-
mate contact and comprise distinct fetal (cotyledon) and maternal
(caruncle) components.
We previously reported that a 3′ deletion in the MIMT1 (MER1
repeat containing imprinted transcript 1) gene was responsible for
paternally inherited IUGR, late abortion, and stillbirth in Ayrshire
cattle [23]. The stillborn calves are typically 50% undersized, but the
MIMT1Del mutation displays variable penetrance. Approximately
15% of MIMT1Del/WT calves undergo full gestation and are healthy
at birth despite reduced weight (authors’ observations).
MIMT1 lies within the imprinted PEG3 (paternally expressed
gene 3) domain and is transcribed as a long noncoding RNA
(lncRNA) (Figure 1A). In mice, bidirectional promoter activity has
been identified at the Peg3-DMR (differentially methylated region)
located between Peg3 and ubiquitin specific peptidase 2 (Usp9) and
has been proposed as an imprinting control region (ICR) [24]. In
mouse, there is no separate MIMT1 gene, the first exon of murine
Usp29 is the same as the first exon in bovine and human MIMT1.
In humans, PEG3 and zinc finger imprinted 2 (ZIM2) have 5′ ex-
ons in common and originate from a single transcript [25]. This
suggests that the MIMT1 transcript may regulate multiple genes at
the 5′ end of the domain. Interestingly, the survival of a propor-
tion of MIMT1Del/WT fetuses suggests that either PEG3 expression
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can be regulated in the absence of MIMT1 in fetal placenta, and/or
maternal placenta plays a role in modifying the extent of growth
restriction in MIMT1Del/WT fetuses.
The aim of this study was to determine the impact of the fe-
tal MIMT1Del mutation on global gene expression in both fetal
and maternal placentome. We examined placenta samples taken be-
fore growth restriction became apparent to identify early, possibly
causative, changes that take place before the onset of global dysreg-
ulation of placental metabolism during IUGR.
Material and methods
Ethics statement
Tissue sampling and insemination were carried out by standard vet-
erinary protocols according to the European Union Normative for
Care and Use of Experimental Animals. All animal experiments were
approved by the Animal Ethics Committee of the State Provincial
Office of Southern Finland (ESAVI-2010-08583/YM-23).
Animals and tissue sampling
A total of 48 tissue samples were collected. That is, the maternal and
fetal placenta sides from 12 cows gestating MIMT1Del/WT fetuses
and 12 cows gestating wild-type fetuses (referred to as wild-type).
Samples were immediately frozen in liquid nitrogen and stored at
–80◦C for further analyses.
DNA and RNA extraction
Genomic DNA was extracted using the GenElute Mammalian Ge-
nomic DNA Kit (Sigma Aldrich), and total RNA extracted using the
Direct-zol RNA Mini Prep Kit (Zymo Research) according to the
manufacturer’s instructions.
Next-generation sequencing (NGS) of the genome
Paired-end libraries were prepared using the paired-end TruSeqDNA
sample prep kit (Illumina Inc., San Diego, CA, USA) and sequenced
using a Illumina HiSeq 2500 instrument (Illumina Inc., San Diego,
CA, USA) to produce 125 bp paired-end reads. The resulting reads
were processed with the Illumina BaseCaller during the sequencing
step. Alignment of reads to the University of Maryland bovine ref-
erence sequence (UMD3.1) [57] was performed with BWA (version
0.6.1-r104) [58] using default parameters. The resulting SAM files
were converted into BAM files with SAMtools (version 0.1.18) [59].
Duplicate reads were identified andmarkedwith theMarkDuplicates
command of Picard (http://picard.sourceforge.net/).
Single nucleotide and short insertion and deletion polymorphisms
were identified using the multisample approach implemented in
SAMtool’s mpileup along with BCFtools [59]. Beagle (version 3.2.1)
phasing was used to improve primary genotype calling by SAMtools.
Functional effects of variants were predicted based on gene annota-
tion of the UMD3.1 assembly of the bovine genome [60].
NGS RNA sequencing
Libraries for RNA sequencing of whole biopsies were prepared using
the TruSeq Stranded mRNA LT Kit (Illumina). RNA integrity and
fragment size were tested using the RNA6000 Nano kit (Agilent) on
an Agilent Bioanalyzer 2100 (Agilent).
Libraries were sequenced with a HiSeq2500 ultra-high-
throughput sequencing system (Illumina) to produce 100-base-
paired end reads. An average of 54 million reads per sample
were generated and mapped to the University of Maryland bovine
reference sequence (UMD3.1) using the 2-pass method of the
STAR aligner with default parameters [61]. A total of 80% of
these reads uniquely hit to the bovine reference genome. Dupli-
cate reads were denoted with the MarkDuplicates command of
Picard (http://broadinstitute.github.io/picard). Aligned reads (omit-
ting duplicate reads) were assigned to gene sequences as defined
in the 10.2.77 porcine gene set and counted with featureCounts
[62]. Normalization of read counts and estimation of fold change
was carried out using DESeq2 [63]. Hierarchical clusters and
heat maps for 20 genes with the most significantly different lev-
els of expression were generated using the R package pheatmap
(https://CRAN.R-project.org/package=pheatmap).
Variant calling based on STAR alignments was performed ac-
cording to GATK [64] best practice recommendations for RNAseq
[65, 66]. The GATK tool SplitNCigarReads was used to split reads
into exons and remove false variants resulting from overhangs. This
step included reassignment of the STAR alignment mapping quali-
ties. GATK recalibration of base scores was based on the Ensembl
release 85 variant database. Variant calling was carried out using
GATKHaplotypeCallerwith the dontUsedSoftClippedBases option.
GATKVariantFiltrationwas applied to clusters of at least three SNPs
within a window of 35 bases between them, with the following pa-
rameters: Fisher strand value >30.0 and a quality by depth value
<2.0. The probability of allelic imbalance for each SNP was calcu-
lated based on the number of reference and alternate allele reads in
heterozygous animals using a two-sided binomial test. P values were
adjusted for FDR (q value) to take account of multiple testing.
Quantitative real-time reverse transcriptase
polymerase chain reaction (RT-PCR)
A total of 500 ng of total RNAwas used to synthesize complementary
DNA (cDNA) using Superscript III reverse transcriptase (Invitrogen).
Two-step quantitative PCR (qPCR) experiments were carried out us-
ing Fast SybrGreen MasterMix (Applied Biosystems) and run on an
ABI 7500 thermocycler (Applied Biosystems). Primer specificity and
capture temperature were determined by melt curve analysis. The
relative expression difference between IUGR (n = 12) and wild-type
(n = 12) in both tissues was calculated for each animal (CT).
All cDNA samples were assayed in triplicate and relative expres-
sion levels normalized to endogenous glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) expression.
Allele quantification using pyrosequencing
Genomic DNA was used for allele quantification using heterozygous
SNPs. An allele proportion of 50:50 at the DNA level for valid py-
rosequencing assays was expected. A total of 200 ng total RNA was
used to synthesize cDNA using Superscript IV reverse transcriptase
(Invitrogen). Complementary DNA was amplified by RT-PCR, and
allele expression for selected SNPs was analyzed by pyrosequencing
using the Pyromark Q24 system (Qiagen). Pyrosequencing primers
were designed using PyroMark Assay Design Software 2.0 (Qiagen).
Allele expression differences at individual SNPs were evaluated using
Student t-test.
Primers
The authors will provide all primer sequences used in this study on
request.
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Results
Experimental overview
The experimental outline is shown in Figure 1B. Growth retardation
of MIMT1Del/WT fetuses occurs in the second and last trimester of
pregnancy. We previously observed major alterations to gene ex-
pression in fetal placenta ofMIMT1Del/WT fetuses [26]. Here, we ex-
plored the effect of theMIMT1Del/WT genotype on the feto–maternal
interaction in the placentome before onset of growth retardation.
We collected fetal and maternal placenta of 12 wild-type and 12
MIMT1Del/WT fetuses terminated at 94 ± 12 days of gestation, all
were gestated in wild-type cows and all were fathered by the same
MIMT1Del/WT sire. Normal gestation in this Bos taurus breed is 280
± 10 days. DNA and total RNA were isolated from fetal and ma-
ternal parts of the placentome, and the transcriptome and genomic
imprinting were analyzed.
Gene expression changes in fetal and maternal
placentome in intrauterine growth restriction fetuses
The transcriptomes of 20 samples (fetal and maternal placenta
samples from 5 cows carrying wild-type fetuses and 5 carrying
MIMT1Del/WT fetuses) were sequenced to a depth of about 54 million
reads per sample to determine transcript levels in fetal and mater-
nal placentome in normal and MIMT1Del/WT fetuses. Expression of
∼20,000 genes was analyzed for all tissue samples.
Genes were ranked by expression log2 fold difference and ad-
justed P value. As expected, the maternal placentome was less af-
fected by fetal genotype than the fetal side: 128 and 308 genes were
differentially expressed in maternal and fetal placentome, respec-
tively. Hierarchical cluster analysis revealed that both tissues formed
relatively homogenous groups (Figure 2C andD).Of the top 50 genes
(SI Appendix, Supplementary Tables S1 and S2, P < 0.005), 11 were
generally expressed at higher level (Figure 2A) and 11 generally at
lower level (Figure 2B) in samples of both fetal and maternal placen-
tome of MIMT1Del/WT fetuses. One gene, AST1 (artiodactyl-specific
transcript 1), showed the most marked difference in expression be-
tween wild-type andMIMT1Del/WT fetuses in both placentome sides,
and was consistently downregulated in fetal (5.63-fold less; FDR
(false discovery rate) = 6.01 × 10−20), and maternal samples (5.37-
fold less; FDR = 0.003). This accords with our previous detection
of decreased AST1 expression in fetal placentome using a microar-
ray [26]. AST1 lies within the PEG3 domain and is transcribed as a
lncRNA with unknown function. Other genes with at least two-fold
decreased expression and P values <0.005 were thrombospondin
1 (THBS1), RAS and EF-hand domain containing (RASEF), phos-
phoglycerate dehydrogenase (PHGDH) in fetal placentome and Ras
association domain family member 6 (RASSF6), glutamate decar-
boxylase 1 (GAD1), baculoviral IAP repeat containing 5 (BIRC5)
in maternal placentome of MIMT1Del/WT fetuses. Genes with the
greatest increase in expression (>two-fold) and known involvement
in prenatal development and fetal growth restriction were meso-
derm specific transcript (MEST), carcinoembryonic antigen related
cell adhesionmolecule 1 (CEACAM1), and coagulation factor V (F5)
in fetal placentome [27–29]; and insulin like growth factor 2 (IGF2),
natriuretic peptide receptor 2 (NPR2), and T-box 3 (TBX3) in ma-
ternal placentome [30, 31]. For example, MEST showed two-fold
higher expression in most fetal and maternalMIMT1Del/WT samples,
suggesting it had undergone loss of imprinting, a finding also ob-
served in human IUGR placenta [32]. IGF2 was expressed higher
in maternal placentome ofMIMT1Del/WT than wild-type fetuses, but
no RNAseq reads mapped to IGF2 in fetal placentome. IGF2 is a
major determinant of placental and fetal growth [10, 33], and our
data suggest that the effect is related to the maternal component in
bovine placenta.
Expression analysis of AST1
AST1 expression data suggested that this gene plays a role in aberrant
placental physiology during IUGR, warranting more detailed analy-
sis. The current assembly of the bovine reference genome (UMD3.1,
UCSC Genome Browser) indicates that AST1 has seven exons [34].
Analyzing raw RNA sequencing data by number of mapped reads,
we found that most sequencing reads aligned to AST1 exons 3, 5,
6, and 7. The number of mapped reads was approximately 10 times
higher in fetal than maternal placentome in wild-type fetuses (Figure
3A and B), and was significantly reduced in both fetal (P = 2.6 ×
10−24) and maternal (P = 1.6 × 10−7) placentome of MIMT1Del/WT
fetuses (Figure 3C). This was also confirmed by qPCR analysis using
primers specific for AST1 exons 5 and 7 in fetal (P = 1.8 × 10−6)
and maternal (P = 6.6 × 10−7) placentome (Figure 3D). Very weak
AST1 expression was detected by RNA sequencing (8± 3 of mapped
reads to each of exons 5, 6, 7) and by qPCR using primers specific
for exons 5 and 7 in fetal placentome of MIMT1Del/WT fetuses (Fig-
ure 3C and D), and none was detected by RNA sequencing or qPCR
analyses of maternal placentome ofMIMT1Del/WT fetuses (Figure 3C
and D). This is consistent with our microarray study on fetal pla-
centome [26], but not with our later study, where AST1 expression
was not detected in maternal normal and IUGR samples [35]. This
could be explained by the ability of different methods to detect less
abundant and multiple RNA-splicing events [36]. Here, we found
that AST1 exon 2 is not expressed in maternal placentome. Using
RT-PCR primers specific for exons 3 and 7, we obtained a 583 bp
PCR product from fetal and maternal placentome homologous to
GenBank AST1 RNA sequence (NR_038119.1) (Figure 3E).
RNA-sequencing-based allelic expression analysis in
placentome of intrauterine growth restriction fetuses
Wenext studied the impact of the fetalMIMT1Del/WT genotype on ge-
nomic imprinting in each placentome component.We first sequenced
the genomes of theMIMT1Del/WT carrier bull, one wild-type and one
MIMT1Del/WT sample to identify placental genomic heterozygous
variants that could be used to detect allele-specific expression (ASE).
Minimum-quality criteria were established to minimize potential
false positive RNA variants, as previously published [37]; these were
≥10RNAseqmapped reads to the reference genome and the presence
of monoallelic expression in fetal and (or) maternal samples. Com-
parison of heterozygous genomic single-nucleotide polymorphism
(SNPs) in the two fetuses with the carrier bull’s genome sequence
revealed ∼16k suitable heterozygous SNPs. Of these, 1444 SNPs
showed unequal ASE, and 132 SNPs showed monoallelic expression
in either fetal ormaternal placentome of wild-type andMIMT1Del/WT
fetuses. We identified 37 strong candidate-imprinted genes that ex-
hibited monoallelic maternal- or paternal-specific expression in the
bovine placentome components. Fifteen of these, including ERO1A
(endoplasmic reticulum oxidoreductase 1 alpha), FN1 (fibronectin
1), SCRN3 (secernin 3),MKI67 (marker of proliferation Ki-67), and
PAG21 (pregnancy-associated glycoprotein 21) showed a different
ASE pattern between wild-type fetal and maternal placentome (SI
Appendix, Supplementary Table S3). In fetal placentome, PEG3,
SCRN3, EIF4G1 (eukaryotic translation initiation factor 4 gamma
1), and RCSD1 (RCSD domain containing 1) showed different ASE
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(A) (B)
(C) (D)
Figure 2. Differentially expressed genes in wild-type andMIMT1Del/WT fetal and maternal placentome: (A) overlap of top 50 upregulated genes between fetal and
maternal IUGR placentome samples; (B) overlap of top 50 downregulated genes between fetal and maternal IUGR placentome samples; (C) heatmap of the top
20 genes showing transcriptome pattern specific for wild-type and IUGR in fetal placentome samples; (D) heatmap of the top 20 genes showing transcriptome
pattern specific for wild-type andMIMT1Del/WT in maternal placentome samples. Genes are ranked by normalized expression differences between the two groups
and P value. AST1 is outlined in red.
between wild-type and MIMT1Del/WT samples. In maternal placen-
tome, HBS1L (HBS1 like translational GTPase), RB1CC1 (RB1 in-
ducible coiled-coil 1), ABCA5 (ATP binding cassette subfamily A
member 5), SCRN3 and MKI67 showed different allele expression
between wild-type andMIMT1Del/WT. RNA-sequencing-based allelic
expression analysis revealed SCRN3 as the only gene that showed
alterations in allele expression affected by the MIMT1Del/WT geno-
type in fetal and maternal placentome (SI Appendix, Supplementary
Table S3). RNAseq read counts in fetal placentome were as follows:
biallelic in wild-type (C/T allele ratio = 21/6) and maternal allele
expression in fetal (C/T allele ratio = 0/15; opposite monoallelic ex-
pression in wild-type (C/T allele ratio = 48/0), and IUGR (C/T allele
ratio = 0/28) maternal placentome was observed. SCRN3 expres-
sion has also been detected in mouse and human placenta [38, 39],
but its function is unknown.
We next analyzed RNA variants that mapped to the PEG3 do-
main and identified 21 SNPs, mainly in exon 10 of the PEG3 gene
(SI Appendix, Supplementary Figure S1). Of these, 12 SNPs showed
homozygous genotypes specific for wild-type and MIMT1Del/WT fe-
tal placentome. A representative SNP, rs110770973 (18:64275283;
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Figure 3. AST1 gene expression in wild-type and IUGR fetal and maternal placentome: (A) RNAseq mapped read counts per exon between wild-type and
MIMT1Del/WT samples in maternal placentome; (B) RNAseq mapped read count per exon between wild-type andMIMT1Del/WT samples in fetal placentome (n = 6
per group); (C) total number of RNAseq mapped reads to all exons in the AST1 gene; (D) qPCR using primers specific for exons 5 and 7 of AST1 in wild-type and
MIMT1Del/WT fetal and maternal placentome (n = 12 per group). Primers located in two different exons provide control for DNA contamination in the samples.
Quantitative PCR measurements were normalized to GAPDH reference gene; (E) 583 bp RT-PCR product amplified using primers hybridizing to exons 3 and 7,
for AST1 isoform specific detection in fetal and maternal placentome. The RT-PCR fragment is homologous to GenBank AST1 RNA sequence (NR 038119.1).
AST1 gene structure based on bovine reference sequence (UMD3.1) in the UCSC Genome Browser.
c.2586C>T; p.Asp862), was used for closer analysis that confirmed
its ASE related to fetal genotype, i.e., paternal allele expression
in wild-type and maternal expression in MIMT1Del/WT fetal pla-
centome (Figure 4A). As in wild-type fetal placentome, this SNP
showed paternal-specific allele expression in maternal placentome
and very few RNAseq reads in MIMT1Del/WT maternal placentome,
which precluded proper genotype calls. Validation of ASE for the
rs110770973 SNP by pyrosequencing confirmedmonoallelic expres-
sion of the C allele (100%) in fetal placentome, and leaky ASE (82%
± 4%) in maternal placenta in MIMT1Del/WT fetuses (Figure 4B).
We also sequenced the entire AST1 gene in all our samples, but
no informative genomic variants for allele expression analysis were
identified.
Discussion
Normal placental function is critical for fetal health, and alterations
to placental gene expression can affect fetal growth [40]. For practi-
cal reasons, transcriptome studies have mainly been applied to sam-
ples of whole placenta. However, the placenta is a heterogeneous
combination of cell types of fetal and maternal origin. Bulk anal-
ysis may not detect or distinguish expression changes in different
components, as are likely when a deleterious fetal mutation such as
MIMT1Del influences placental function. Our earlier study on PEG3
gene expression suggested that the fetal MIMT1Del/WT genotype pri-
marily affects the fetal part of the placentome [35].
We examined the impact of fetal MIMT1Del on global gene ex-
pression in both fetal and maternal placentome to identify tran-
scriptome changes leading to IUGR. This approach revealed AST1
to be significantly downregulated in both sides in cattle gestating
MIMT1Del/WT fetuses. Bovine AST1 is located in the PEG3 domain
at a locus orthologous to Zim2 (zinc finger, imprinted 1) in mouse
and ZIM2 in human. It has been suggested that mouse Peg3 neg-
atively regulates Zim1 [41]. We however observed decreased ex-
pression of both PEG3 and AST1, suggesting these genes have a
different relationship in cattle, reflecting interspecies differences in
PEG3 regulation [42]. Our finding that AST1 downregulation oc-
curs in early-stage IUGR is intriguing. The function of this gene and
its place in PEG3 domain regulation is so far unknown, but certainly
worthy of further investigation.
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(A) (B)
Figure 4. Allele-specific expression of PEG3 in wild-type and IUGR fetal and maternal placentome: (A) a fragment of aligned PEG3 exon 10 sequencing reads
of wild-type (top) and IUGR fetus (bottom). Allele calls for the C/T rs64275283 SNP are marked; (B) allele expression ratio for the PEG3 C/T rs64275283 SNP
(wild-type, n = 6; IUGR, n = 7) measured by pyrosequencing.
It seems likely that the principal mechanism of IUGR in the
bovine MIMT1Del model is mediated via PEG3 and its downstream
target genes. Other genes identified as differentially expressed in
bovine placenta of MIMT1WT/Del fetuses such as F5, CEACAM1,
and RASSF8 (Ras association domain family member 8) were also
differentially expressed in early placenta of Peg3-deficient mice [43].
PEG3 is expressed in all placenta tissues in mouse and human [44,
45], and Peg3-deficient mice show fetal growth restriction and small
but histologically normal placentae [27]. Similarly, MIMT1WT/Del
bovine fetuses have decreased placental PEG3 expression, and have
smaller but normal placentae [23]. PEG3 is a well-known regulator
of Wnt signaling, which plays an important role in placenta develop-
ment [46], but also controls the transcription of groups of placenta-
specific genes [43]. Disruption of Peg3 function in mice also leads
to aberrant expression of placenta-specific genes, for example in fe-
tal brain [43], an effect similar to that we observe in MIMT1WT/Del
bovine fetuses [47].
Together with our previous data [26, 35], our findings suggest
that the MIMT1 transcript is a regulator of genes at the 5′ end of
the PEG3 domain. The region of MIMT1 defined by the MIMT1Del
deletion contains evolutionarily conserved regions, which we pro-
pose act as cis-regulatory elements for PEG3 and other imprinted
genes in the domain, as previously reported in mouse and human
[48, 49]. Further studies of mice and humans are needed to elucidate
the functions of AST1 and ZIM1 in prenatal development.
Although there is only limited invasion of fetal cells into the ma-
ternal side of synepitheliochorial placenta, they can influence the
maternal component of the placentome and thus maternal physiol-
ogy, and molecules of fetal origin have been detected in maternal
blood circulation in cattle [50]. Moreover, embryo transfer exper-
iments in domestic animals have shown that that the fetal genome
influences placental concentrations of hormones and growth fac-
tors [51, 52]. Fetal growth is associated with placenta size [53],
and is controlled by parent-specific monoallelic expression [54]. We
identified 37 genes showing monoallelic expression in the bovine
placentome, three of which were located in three imprinted clus-
ters: MEST/COPG2, H19/IGF2 and particularly the PEG3/USP29
domain, regulation of which was affected by the MIMT1Del/WT fetal
genotype. Most of these genes (n = 26) have not previously been
described as placental-imprinted in cattle or other mammals [37, 55,
56], possibly indicating that the imprinting status of these genes is
restricted to the placentome in cattle. This is consistent with other
studies that have reported that species-specific allele expression of
distinct imprinted genes is responsible for the evolutionary diver-
sity of placenta types [55, 56]. It is unlikely that we identified all
SNPs that would exhibit ASE, but the genes that were analyzed,
particularly PEG3, clearly indicated differential allele expression in
fetal and maternal placentome. This is an important finding because
parental-specific monoallelic expression in placenta balances fetal
growth. Abnormal monoallelic maternal expression of PEG3 in fe-
tal MIMT1Del/WT samples could explain the restricted growth of fe-
tuses, because maternally expressed genes act as negative regulators
of prenatal development. We suggest that the phenomenon whereby
∼15% of MIMT1Del/WT calves complete full gestation could be as-
sociated with leaky (∼80:20) rather than strictly monoallelic PEG3
allele expression in the maternal placenta of those fetuses.
Our study revealed that few genes are affected in both placen-
tome components by fetal genotype, showing that maternal and fetal
placental cells respond differently to the fetal IUGR genotype. Cau-
tion is therefore warranted when analyzing gene expression changes
in nondissected samples of placenta. To some extent, single-cell tran-
scriptomics can improve the detection of allele-specific gene expres-
sion in placenta [17].
In conclusion, we have expanded the list of candidate-imprinted
genes in bovine placenta and demonstrated that abnormal monoal-
lelic PEG3 expression leads to IUGR. The nonprotein coding
MIMT1 and AST1 genes probably regulate the parental-allele speci-
ficity of PEG3 expression. Our unique genetic IUGR model has also
revealed that maternal placenta modulates the penetrance of muta-
tions in the fetal genome.
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Supplementary Figure S1. Genotype distribution at polymorphic
loci in the PEG3 gene obtained by RNAseq data analysis of wild-type
(n = 10) and IUGR (n = 10) fetal and maternal placentome.
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